HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshitake Kanbe Selected Research

CH 4893237

3/2009Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels.
8/2005Identification of a novel, orally bioavailable estrogen receptor downregulator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshitake Kanbe Research Topics

Disease

3Neoplasms (Cancer)
03/2010 - 08/2005
3Breast Neoplasms (Breast Cancer)
03/2010 - 08/2005
1Pain (Aches)
08/2005
1Inflammation (Inflammations)
08/2005
1Endometrial Neoplasms (Endometrial Cancer)
08/2005

Drug/Important Bio-Agent (IBA)

3Estrogen ReceptorsIBA
03/2010 - 08/2005
3Fulvestrant (Faslodex)FDA Link
03/2010 - 08/2005
3TamoxifenFDA LinkGeneric
03/2010 - 08/2005
2CH 4893237IBA
03/2009 - 08/2005
1CH 4986399IBA
03/2010
1Selective Estrogen Receptor Modulators (SERM)IBA
03/2010
1Aromatase InhibitorsIBA
03/2009
1Estrogens (Estrogen)FDA Link
03/2009
1Hormones (Hormone)IBA
08/2005
1Pharmaceutical PreparationsIBA
08/2005